How to buy Eton Pharmaceuticals stock | $8.66

Eton Pharmaceuticals, Inc is a biotechnology business based in the US. Eton Pharmaceuticals shares (ETON) are listed on the NASDAQ and all prices are listed in US Dollars. Eton Pharmaceuticals employs 17 staff and has a trailing 12-month revenue of around USD$417,000.

How to buy shares in Eton Pharmaceuticals

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Eton Pharmaceuticals. Find the stock by name or ticker symbol: ETON. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Eton Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$8.66, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Eton Pharmaceuticals, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Eton Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Eton Pharmaceuticals share price

Use our graph to track the performance of ETON stocks over time.

Eton Pharmaceuticals shares at a glance

• Key figures

Information last updated 2020-12-27.

Latest market close	USD$8.66
52-week range	USD$2.5 - USD$9.12
50-day moving average	USD$7.9567
200-day moving average	USD$7.0685
Wall St. target price	USD$16.5
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-3.071

Buy Eton Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Eton Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Eton Pharmaceuticals, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Eton Pharmaceuticals price performance over time

Historical closes compared with the close of $8.66 from 2020-12-09

1 week (2021-01-15)	-4.52%
1 month (2020-12-23)	-0.12%
3 months (2020-10-22)	9.07%
6 months (2020-07-22)	48.03%

1 year (2020-01-22)	25.69%
2 years (2019-01-22)	41.97%
3 years (2018-01-19)	N/A
5 years (2016-01-19)	N/A

Eton Pharmaceuticals financials

Revenue TTM	USD$417,000
Gross profit TTM	USD$506,000
Return on assets TTM	-112.18%
Return on equity TTM	-334.58%
Profit margin	0%
Book value	$0.066
Market capitalisation	USD$212.6 million

TTM: trailing 12 months

Shorting Eton Pharmaceuticals shares

There are currently 851,569 Eton Pharmaceuticals shares held short by investors – that's known as Eton Pharmaceuticals's "short interest". This figure is 18% down from 1.0 million last month.

There are a few different ways that this level of interest in shorting Eton Pharmaceuticals shares can be evaluated.

Eton Pharmaceuticals's "short interest ratio" (SIR)

Eton Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Eton Pharmaceuticals shares currently shorted divided by the average quantity of Eton Pharmaceuticals shares traded daily (recently around 199898.82629108). Eton Pharmaceuticals's SIR currently stands at 4.26. In other words for every 100,000 Eton Pharmaceuticals shares traded daily on the market, roughly 4260 shares are currently held short.

However Eton Pharmaceuticals's short interest can also be evaluated against the total number of Eton Pharmaceuticals shares, or, against the total number of tradable Eton Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eton Pharmaceuticals's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Eton Pharmaceuticals shares in existence, roughly 40 shares are currently held short) or 0.0563% of the tradable shares (for every 100,000 tradable Eton Pharmaceuticals shares, roughly 56 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Eton Pharmaceuticals.

Find out more about how you can short Eton Pharmaceuticals stock.

Eton Pharmaceuticals share dividends

We're not expecting Eton Pharmaceuticals to pay a dividend over the next 12 months.

Eton Pharmaceuticals share price volatility

Over the last 12 months, Eton Pharmaceuticals's shares have ranged in value from as little as $2.5 up to $9.12. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eton Pharmaceuticals's is 1.2887. This would suggest that Eton Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Eton Pharmaceuticals overview

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.

Frequently asked questions

• What percentage of Eton Pharmaceuticals is owned by insiders or institutions?

  Currently 28.033% of Eton Pharmaceuticals shares are held by insiders and 29.144% by institutions.

• How many people work for Eton Pharmaceuticals?

  Latest data suggests 17 work at Eton Pharmaceuticals.

• When does the fiscal year end for Eton Pharmaceuticals?

  Eton Pharmaceuticals's fiscal year ends in December.

• Where is Eton Pharmaceuticals based?

  Eton Pharmaceuticals's address is: 21925 West Field Parkway, Deer Park, IL, United States, 60010-7208

• What is Eton Pharmaceuticals's ISIN number?

  Eton Pharmaceuticals's international securities identification number is: US29772L1089

• What is Eton Pharmaceuticals's CUSIP number?

  Eton Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 29772L108